Trial of Chinese Prescription on Ulcerative Colitis

N/ACompletedNCT00963287

Shanghai University of Traditional Chinese Medicine200 enrolled

Overview

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription on Ulcerative Colitis.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

200

Conditions

Ulcerative Colitis

Interventions

bascial prescription plus or minus herbs depend on symptomsDRUG

Decoction ,two times a day

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of ulcerative colitis * Male of female patients between 18-65 years old * Written informed consent Exclusion Criteria: * Combine with malignant pathology on epithelial dysplasia of mucosa * Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease. * Pregnancy or breast feeding women, or unwilling to have contraception.

Locations (1)

Longhua hospital

Shanghai, Shanghai Municipality, China

Outcomes

Primary Outcomes

Histopathological examination,enteroscopy,blood test,symptoms ,pulse tracings,tongue demonstration

Time frame: 8 weeks

Secondary Outcomes

Indicates of liver and renal function

Time frame: 8 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.